These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 4202342)

  • 1. Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.
    Lockwood WR; Lawson LA
    Antimicrob Agents Chemother; 1973 Sep; 4(3):281-4. PubMed ID: 4202342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
    Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
    J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro sensitivity of isolates of Pseudomonas aeruginosa to carbenicillin, gentamicin, tobramycin, and some other antibiotics.
    Wretland B; Nord CE; Wadström T
    Scand J Infect Dis; 1974; 6(1):49-52. PubMed ID: 4208204
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Chemotherapy; 1979; 25(1):48-53. PubMed ID: 253637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B.
    Duncan IB
    Antimicrob Agents Chemother; 1974 Jan; 5(1):9-15. PubMed ID: 4365116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
    Marks MI; Hammerberg S; Greenstone G; Silver B
    Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic sensitivity of two Aeromonas and nine Pseudomonas species.
    Nord CE; Wadström T; Wretlind B
    Med Microbiol Immunol; 1975; 161(2):89-97. PubMed ID: 1040755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.
    Anderson EL; Gramling PK; Vestal PR; Farrar WE
    Antimicrob Agents Chemother; 1975 Sep; 8(3):300-4. PubMed ID: 810083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of antimicrobial susceptibility of Pseudomonas aeruginosa by disk diffusion and microdilution methods.
    Cox HU; Luther DG
    Am J Vet Res; 1980 Jun; 41(6):906-9. PubMed ID: 6776851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.
    Kluge RM; Standiford HC; Tatem B; Young VM; Greene WH; Schimpff SC; Calia FM; Hornick RB
    Antimicrob Agents Chemother; 1974 Oct; 6(4):442-6. PubMed ID: 4157342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
    Klastersky J; Nyamubeya B; Vandenborre L
    J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin.
    Klastersky J; Henri A; Vandenborre L
    Am J Med Sci; 1973 Jul; 266(1):13-21. PubMed ID: 4198684
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of Pseudomonas aeruginosa strains possessing R factor in a hospital.
    Kawakami Y; Mikoshiba F; Nagasaki S; Matsumoto H; Tazaki T
    J Antibiot (Tokyo); 1972 Oct; 25(10):607-9. PubMed ID: 4630693
    [No Abstract]   [Full Text] [Related]  

  • 14. [Isolation rate of Pseudomonas aeruginosa from clinical materials and its susceptibility to antibiotics].
    Oguri T; Kosakai N
    Jpn J Antibiot; 1971 Jun; 24(3):121-5. PubMed ID: 4327335
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the antibacterial activity of aminoglycoside antibiotics and their combinations with carbenicillin against Pseudomonas aeruginosa].
    Iakushkina IV; Shapovalova SP; Malkova IV
    Antibiotiki; 1982 Aug; 27(8):601-7. PubMed ID: 6812489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiresistant plasmids from Pseudomonas aeruginosa highly resistant to either or both gentamicin and carbenicillin.
    Kontomichalou P; Papachristou E; Angelatou F
    Antimicrob Agents Chemother; 1976 Jun; 9(6):866-73. PubMed ID: 820245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.
    Yu PK; Washington JA
    Mayo Clin Proc; 1977 Dec; 52(12):802-5. PubMed ID: 413013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1980 Jun; 33(6):668-74. PubMed ID: 6779031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum.
    Reyes MP; El-Khatib MR; Brown WJ; Smith F; Lerner AM
    J Infect Dis; 1979 Aug; 140(2):192-202. PubMed ID: 113468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.